News Sentiment

PCSC sentiment intelligence

Perceptive Capital Solutions Corp Class A Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Financial Services Market context
Industry Shell Companies Read-through group
Latest close 11.40 Week of 12 Jun 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+2.6% over one week, +2.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

SEC declares Perceptive Capital and Freenome merger effective

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 2.6% Price confirming higher
Trend fit Trend inactive 2.9% over four weeks
Fair value 5.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 27
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 17
TradingKey 9
MarketBeat 4
scanx.trade 1
Moomoo 1
TradingView 1
StockStory 1
Investing.com India 1

Event Lens

What the news is about

Classified themes
Market update 23
Deals and strategy 12
Earnings 5
Analyst action 3
Regulatory and legal 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45
Minichart Direct company coverage

Perceptive Capital Solutions Corp 2025 Annual Report: Business Combination Strategy, Risks, and Freenome Agreement Overview

Perceptive Capital Solutions Corp. (PCSC) released its 2025 Annual Report, highlighting its status as a blank check company formed in March 2024 with no operating revenues to date. The primary focus of the report is the proposed business combination with Freenome, outlining signi

Tone
Neutral 50/100
Event
Market update
Published
12 Mar 2026 22:52
Source
Minichart
Stock Titan Direct company coverage

Commodore Capital reports 0% PCSC (NASDAQ: PCSC) ownership in 13G/A

Commodore Capital LP and Commodore Capital Master LP have filed an amended Schedule 13G/A, reporting that they no longer beneficially own any Class A ordinary shares of Perceptive Capital Solutions Corp (NASDAQ: PCSC). As of December 31, 2025, their ownership stands at 0%, indica

Tone
Neutral 50/100
Event
Market update
Published
18 Feb 2026 03:52
Source
Stock Titan
MarketBeat Direct company coverage

Perceptive Capital Solutions Corp. (NASDAQ:PCSC) Short Interest Update

Perceptive Capital Solutions Corp. (NASDAQ:PCSC) experienced a significant 169.0% surge in short interest in December, reaching 757,478 shares, which represents 8.5% of its shares outstanding. The stock currently has a short-interest ratio of 7.1 days and a consensus "Sell" ratin

Tone
Negative 37/100
Event
Market update
Published
14 Jan 2026 12:57
Source
MarketBeat
Stock Titan Direct company coverage

PCSC SEC Filings - Perceptive Cap 10-K, 10-Q, 8-K Forms

This page provides access to SEC filings for Perceptive Capital Solutions Corp (PCSC), a SPAC listed on Nasdaq focused on the financial services and healthcare sectors. It includes annual reports (10-K), quarterly reports (10-Q), material event reports (8-K), and insider trading

Tone
Neutral 50/100
Event
Market update
Published
13 Jan 2026 17:40
Source
Stock Titan
MarketBeat Direct company coverage

Perceptive Capital Solutions (NASDAQ:PCSC) Shares Up 2.2% - Here's Why

Perceptive Capital Solutions (NASDAQ:PCSC) saw its shares rise 2.2% on Thursday, trading as high as $12.75 with a significant increase in trading volume. Despite this uptick, analyst sentiment remains negative, with Weiss Ratings reiterating a "Sell" rating for the company. Insti

Tone
Negative 38/100
Event
Analyst action
Published
19 Dec 2025 08:09
Source
MarketBeat
Mondaq Direct company coverage

United States - Goodwin Advised Freenome On $330 Million DeSPAC With Perceptive Capital Solutions At A Target $1.1 Billion Valuation

Goodwin Procter LLP advised Freenome on a definitive business combination agreement with Perceptive Capital Solutions Corp (PCSC), a SPAC. This DeSPAC transaction is valued at approximately $330 million, expecting to result in a post-transaction equity value of $1.1 billion. Free

Tone
Positive 70/100
Event
Analyst action
Published
11 Dec 2025 22:09
Source
Mondaq
Dealbreaker Direct company coverage

Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC Merger

Freenome, a developer of liquid biopsy tests for early cancer detection, is going public through a SPAC merger with Perceptive Capital Solutions Corp, bringing in $330 million to advance its pipeline. The company's colorectal cancer test, SimpleScreen, is currently under FDA revi

Tone
Positive 77/100
Event
Deals and strategy
Published
09 Dec 2025 13:09
Source
Dealbreaker
Indian Pharma Post Direct company coverage

Freenome strikes SPAC deal to go public in 2026

Biotech company Freenome Holdings will go public in the first half of 2026 through a merger with Perceptive Capital Solutions Corp, a SPAC. The transaction is expected to bring in approximately $330 million in proceeds for the combined company, accelerating the development of Fre

Tone
Positive 73/100
Event
Deals and strategy
Published
08 Dec 2025 08:09
Source
Indian Pharma Post
Stock Titan Direct company coverage

Freenome to go public with PCSC (Nasdaq: PCSC) in $1.1B SPAC, $240M PIPE deal

Freenome is set to become a publicly listed company, trading as FRNM on Nasdaq, through a definitive business combination agreement with Perceptive Capital Solutions Corp (PCSC). This $1.1 billion SPAC deal includes a $240 million PIPE investment led by Perceptive Advisors and RA

Tone
Positive 72/100
Event
Deals and strategy
Published
05 Dec 2025 14:09
Source
Stock Titan
MSN Direct company coverage

Perceptive Capital Solutions announces merger with Freenome

This article announces that Perceptive Capital Solutions has merged with Freenome. The merger brings together a capital solutions provider with an innovative health technology company. Further details regarding the implications of this merger for both companies and their stakehol

Tone
Positive 75/100
Event
Deals and strategy
Published
05 Dec 2025 14:09
Source
MSN
TipRanks Direct company coverage

Freenome, Perceptive Capital Solutions announce business combination agreement

Freenome Holdings and Perceptive Capital Solutions (PCSC) have announced a definitive business combination agreement. Upon closing, PCSC will redomicile as a Delaware corporation, be renamed Freenome, and list on Nasdaq under the ticker symbol “FRNM.” The transaction, expected to

Tone
Positive 72/100
Event
Market update
Published
05 Dec 2025 14:09
Source
TipRanks
www.marketscreener.com Direct company coverage

Freenome Holdings, Inc. entered into a definitive business combination agreement to acquire Perceptive Capital Solutions Corp from Perceptive Capital Solutions Holdings and others in a reverse merger transaction for $330 million.

Freenome Holdings, Inc. has entered into a definitive business combination agreement to acquire Perceptive Capital Solutions Corp in a reverse merger transaction valued at $330 million. Upon closing in the first half of 2026, Perceptive Capital Solutions Corp will be renamed Free

Tone
Positive 70/100
Event
Deals and strategy
Published
05 Dec 2025 14:09
Source
www.marketscreener.com
BioWorld MedTech Direct company coverage

Cancer blood test maker Freenome going public with $330M SPAC

Freenome Holdings Inc., a developer of blood-based cancer screening tests, is set to go public through a $330 million SPAC deal. The transaction involves an affiliate of Perceptive Advisors and includes $240 million in equity investments, with the funds primarily intended for the

Tone
Neutral 50/100
Event
Deals and strategy
Published
05 Dec 2025 06:29
Source
BioWorld MedTech